Likarda

Cell-based encapsulation systems designed to protect, deliver, and sustain the function of living cells at the target site.

Likarda’s proprietary platform technology encapsulates cells, peptides, proteins, antibodies, and scaffolds in injectable hydrogel microbeads.

Solutions that protect therapeutic cells and compounds during storage and transport—eliminating the need for liquid nitrogen and reducing environmental impact.

CSS supports early-stage drug development with a wide range of preclinical applications across biologics, peptides, small molecules, and cell therapies.

The Likarda blog features posts about cell therapy, biocompatibility, and other topics from Likarda scientists.

The on-demand webinar discusses advancements in hormone replacement therapy and their potential impact on patient care.

Find publications, research articles, and white papers from the scientists at Likarda.

Likarda offers videos and webinars from its scientists and industry leaders.

Likarda, LLC announces the appointment of Shelly Adams as Chief Commercial Officer. Adding experience in cell culture, and bringing molecules from discovery to launch.

The page covers Likarda’s upcoming events and new developments.

Likarda seeks scientific talent with experience in hydrogel chemistry.

Likarda’s team includes leaders and scientists working with cell and hydrogel technologies for therapeutic applications.

Likarda combines deep scientific expertise with a practical understanding of manufacturing and regulation, guided by decades of experience in cell therapy.

Likarda works on delivery and formulation challenges in healthcare.

Likarda provides technologies for small molecules, biologics, and cell therapies using its Core-Shell Spherification (CSS) encapsulation platform.

Likarda’s privacy policy explains how the company collects and uses personal data and how people can control their information.

The page describes the terms and conditions governing use of the Likarda website and outlines its copyright, disclaimer, and trademark policies.